Company Number: 13658981

Analysis Date: 2025-07-20 18:56 UTC

Financial Health Assessment of UNOBTRUSIVE LTD

---

1. Financial Health Score: D

Explanation:
The company shows signs of financial strain with a negative net working capital (net current assets), very low net assets, and shrinking shareholder funds over the past two years. While it remains active and solvent, these vital signs indicate vulnerability and limited financial cushion to absorb shocks.

---

2. Key Vital Signs

Metric	2023 (£)	2022 (£)	Interpretation
Fixed Assets	3,162	3,283	Stable but minimal long-term asset base — typical for a micro design business
Current Assets	48,675	800	Large increase mainly likely cash or receivables, but overall liquidity is questionable due to…
Current Liabilities	50,248	2,363	Sharp rise in short-term obligations, creating a working capital deficit
Net Current Assets	-1,573	-1,563	Negative working capital ("symptom of distress") — company may struggle to meet short-term debts
Total Assets Less Current Liabilities	1,589	1,720	Slightly declining asset coverage after short-term debts, showing limited buffer
Net Assets / Shareholders Funds	425	700	Very low equity base, eroding over time — "thin financial artery" risking insolvency
Average Employees	1	1	Small scale operation, limiting economies of scale

Additional Notes:

• The company is a micro-entity, so financial data is limited but still shows persistent working capital challenges.
• The increase in current assets from £800 to £48,675 is striking; this may reflect timing issues in receivables or cash but is offset by rising current liabilities.
• Accruals and deferred income rose slightly, indicating possible revenue recognition timing effects.

---

3. Diagnosis

UNOBTRUSIVE LTD exhibits symptoms akin to a patient with a weak cardiovascular system — the "blood flow" of cash is inconsistent and strained. The persistent negative working capital reveals that the company does not have enough short-term assets (cash, receivables) to cover its immediate liabilities. This situation is often a red flag for liquidity distress and potential solvency risk if not addressed.

The erosion of net assets (shareholders’ equity) over the last two years indicates the business is gradually losing its financial "muscle." Although the company remains solvent with positive net assets, the margin is very slim, leaving little room for error or unexpected expenses.

Given the micro-entity nature and single-director setup, this could be a normal phase for a young company still establishing its market presence; however, without improvements, the company risks "financial fatigue" that could lead to cash flow crises or inability to meet creditor demands.

---

4. Recommendations

To improve financial wellness and avoid further deterioration, the company should consider the following:

1. Improve Working Capital Management:

   • Accelerate collection of receivables and/or negotiate better payment terms with suppliers to reduce current liabilities.
   • Monitor cash flow closely to avoid shortfalls.

2. Cost Control and Revenue Growth:

   • Evaluate operational costs to identify any inefficiencies or non-essential expenditures.
   • Pursue targeted marketing or business development to increase sales and improve profitability.

3. Strengthen Equity Base:

   • Consider capital injection from the sole shareholder or external investors to boost net assets and provide a financial cushion.
   • Retain earnings within the company rather than distributing profits (if any) to build reserves.

4. Financial Planning and Forecasting:

   • Implement regular budgeting and cash flow forecasting to anticipate liquidity needs and plan accordingly.
   • Seek professional advice if cash flow problems persist to explore restructuring or financing options.

5. Maintain Compliance and Reporting:

   • Continue timely filing of accounts and confirmation statements to maintain good standing and avoid penalties.

---